Source : BUSINESS WIRE
BLOOMINGTON, Ind.--(BUSINESS WIRE)--Cook
Medical has launched a new treatment option for otolaryngologists
(ear, nose and throat specialists) who repair the dura mater following
cerebrospinal fluid (CSF) leaks at the base of the skull. Cook’s
Biodesign® Duraplasty Graft is the latest Biodesign product from Cook
and Neck Surgery (OHNS) clinical division.
A dura substitute, the Biodesign Duraplasty Graft is used to repair the
dura mater and prevent CSF leaks following surgical procedures at the
skull base (e.g. tumor resection). In other cases, the graft may be used
to treat existing CSF leaks such as those resulting from trauma or sinus
surgery at the skull base.
During the repair procedure, the Biodesign graft is easy to manipulate,
because of its advanced handling characteristics. The graft doesn’t
swell when hydrated and doesn’t fold onto itself. The graft can be
placed with or without sutures and can achieve a strong seal,1
so it provides a well-balanced treatment option for dura mater repair at
the skull base. Another benefit of Biodesign is that it reduces the need
to harvest tissue from other parts of the body for use in the repair.
“I started using Biodesign because I found it easier to handle during
the endoscopic repair than competing products,” said Bradford A.
Woodworth, M.D., director of otolaryngology research at the University
of Alabama at Birmingham, in a letter to the U.S. Food and Drug
Administration in which he evaluated the new device. "Although not
directly measured, [I] feel it contributes to faster graft placement and
increased operative speed."
“Biodesign’s proven tissue repair technology works in different grafting
procedures,” said Thomas Cherry, R.N., OHNS global clinical division
leader for Cook Medical. “We’re excited to introduce the device to
otolaryngologists and expand OHNS’s Biodesign line. Because of
Biodesign’s excellent handling characteristics, physicians can secure
the Biodesign graft during skull-base dura mater reconstruction with or
Cook’s proprietary Biodesign graft technology is derived from a natural
material. It is designed to enable physicians to easily manipulate and
secure the graft. Biodesign has been used since 1998 to treat more than
750,000 patients worldwide. Biodesign is non-dermis based and
non-cross-linked so that the body can remodel it into strong,
Note: Dr. Bradford Woodworth is a paid consultant to Cook Medical
with respect to its medical devices.
About Cook Medical
Since 1963 Cook Medical has worked closely with physicians to develop
technologies that eliminate the need for open surgery. Today we are
combining medical devices, biologic materials and cellular therapies to
help the world's healthcare systems deliver better outcomes more
efficiently. We have always remained family-owned so that we have the
freedom to focus on what we care about: patients, our employees and our
communities. Find out more at www.cookmedical.com, and
for the latest news, follow us on Twitter,
Facebook and LinkedIn. Follow
Cook OHNS @CookOHNS.
1 Benjjani GK, Zabramski J; Durasis Study Group. Safety and
efficacy of the porcine small intestinal submucosa dural substitute:
results of a prospective multicenter study and literature review. J